Can Restless Legs Syndrome (RLS) cause heart problems?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can RLS Cause Heart Problems?

Restless Legs Syndrome (RLS) itself does not directly cause heart disease, but emerging evidence suggests an association between RLS and increased cardiovascular risk, likely mediated through periodic leg movements that trigger repetitive blood pressure and heart rate surges, along with sleep fragmentation that may increase sympathetic nervous system activity. 1, 2

Understanding the Cardiovascular Connection

The relationship between RLS and cardiovascular disease remains an area of active investigation, with mixed but concerning findings:

  • Periodic leg movements during sleep (PLMS), which occur in 60-80% of RLS patients, are associated with brief, recurrent elevations in heart rate and blood pressure approximately every 15-30 seconds throughout the night. 3, 1

  • These repetitive cardiovascular surges may affect the normal physiological nocturnal blood pressure dip, potentially leading to increased cardiovascular disease incidence over time. 1

  • Cross-sectional and longitudinal epidemiologic studies have reported associations between RLS and both cardiovascular disease and hypertension, though the magnitude and direction of these associations remain inconclusive. 1, 4

Potential Mechanisms of Cardiovascular Risk

Several pathways may explain how RLS could contribute to cardiovascular problems:

  • Sleep fragmentation and deprivation linked to sensory discomfort in RLS may increase sympathetic nervous system tone, contributing to elevated cardiovascular risk. 1, 2

  • Iron deficiency, a key pathophysiologic feature of RLS, is emerging as an independent risk factor for cardiovascular disease. 2

  • Increased central sympathetic outflow, impaired baroreflex function, and diminished heart rate and blood pressure variability may occur, similar to mechanisms seen in obstructive sleep apnea. 2

  • Potential metabolic consequences including glucose intolerance and reduced insulin sensitivity from chronic sleep disturbance may contribute to cardiovascular risk. 2

Clinical Implications and Quality of Life Impact

Beyond potential cardiovascular effects, RLS significantly impacts overall health:

  • RLS affects quality of life at least as severely as other common chronic illnesses, particularly resulting in insomnia, anxiety, and depression. 5

  • Severe RLS symptoms can negatively impact sleep, mood, and quality of life, with moderate-to-severe disease affecting at least 2.7% of the population. 5

  • RLS may be a risk factor for cardiovascular disease, though this relationship requires further investigation to establish causality. 6

Important Caveats

  • The epidemiologic evidence is mixed—not all cross-sectional and longitudinal studies have found meaningful associations between RLS and cardiovascular disease. 2

  • Comorbidities and associated sleep disorders may synergistically increase cardiovascular risk, making it difficult to isolate RLS as an independent causative factor. 1

  • The relationship may be bidirectional or confounded by shared risk factors rather than representing direct causation. 1

Management to Reduce Cardiovascular Risk

Treating RLS effectively may theoretically reduce cardiovascular risk by addressing the underlying mechanisms:

  • First-line treatment with alpha-2-delta ligands (gabapentin, gabapentin enacarbil, or pregabalin) can reduce symptoms and improve sleep quality. 7

  • Correcting iron deficiency (when ferritin ≤75 ng/mL or transferrin saturation <20%) addresses both RLS pathophysiology and a potential independent cardiovascular risk factor. 7, 2

  • Avoiding medications that worsen RLS (tricyclic antidepressants, SSRIs, lithium, dopamine antagonists) prevents symptom exacerbation. 3

  • Greater multidisciplinary collaboration between cardiologists and sleep specialists is needed to better identify, understand, and manage patients with RLS who may be at cardiovascular risk. 1

References

Guideline

Limb Movements During Wakefulness After Sleep Onset and Their Correlation with Restless Leg Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Restless legs syndrome.

Nature reviews. Disease primers, 2021

Research

[Diagnosis and symptom rating scale of restless legs syndrome].

Brain and nerve = Shinkei kenkyu no shinpo, 2009

Guideline

Management of Restless Legs Syndrome (RLS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.